Mesoscale Discovery Promo

It’s hard to imagine we’ve already left 2020 behind us. In the new year, we at MSD are committed to continually evolving our technology platform to enable researchers such as yourself to solve complex biological questions in areas such as drug discovery, basic medical research and companion diagnostics. To help accommodate funding in the new […]

Mesoscale Discovery End-of-year Promo

Orders must be in by Friday, December 18th to ensure delivery before January 12th, 2021 .  Save 50% on our fg/mL level ultra-sensitive assay platform (link to S-PLEX )  Save between 20% and 30% on select R-PLEX antibody pairs and assays (link to R-PLEX )  Save between 20% and 30% on select U-PLEX kits (link to U-PLEX )  Save between 20% and 25% on […]

Wear White for a Future 2020

On June 12, 2020, the IML and the Shreiber Lab participated in Wear White for a Future.  By wearing white together, we are standing for science and the search for immune-based cures. Wear White Day is critical part of June’s Cancer Immunotherapy Month awareness and education programs. #Immune2Cancer

50% OFF any S-PLEX assay thru March 31, 2020

Accurate, reliable fg/ml biomarker measurements at the bench? — No Problem!! JUST LAUNCHED!! NEW MSD S-PLEX Ultra-Sensitive Assays.  Drive your biomarker measurements down to new LOWS!! Unlike other companies – MSD won’t make you buy new instrumentation to take advantage of this groundbreaking technology and assays. S-PLEX kits can be run on our S600, SQ120, […]

Wear White for a Future (Links to an external site)

Wear White 2019 - Schreiber Lab

On June 14, 2019, the Shreiber Lab participated in Wear White for a Future.  By wearing white together, they are standing for science and the search for immune-based cures. Wear White Day is critical part of June’s Cancer Immunotherapy Month awareness and education programs. #Immune2Cancer

A chat with the chancellor (Links to an external site)

Chancellor Wrighton photo

Chancellor Mark S. Wrighton lists Bob Schreiber’s work on immunological approaches to ­dealing with ­diseases, including cancer as an accomplishment that has made one of the biggest impact during his tenure.

Schreiber elected AACR Academy fellow (Links to an external site)

Robert Schreiber Photo

Robert D. Schreiber, PhD, the Andrew M. and Jane M. Bursky Distinguished Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has been elected a fellow of the American Association for Cancer Research (AACR) Academy.

$3.4 million aids effort to make a better flu vaccine (Links to an external site)

Nurse administers flue vaccine

Ali Ellebedy, PhD (an assistant professor of pathology and immunology and a researcher with the Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs) and colleagues will compare how people’s immune systems respond to the yellow-fever vaccine and the inactivated flu vaccine to better understand how vaccines elicit long-lasting immune responses. In contrast to the flu vaccine, the yellow-fever vaccine provides robust life-long immunity.

The warrior within (Links to an external site)

Bob Schreiber Photo in Lab

Immune-based therapies are becoming a reality for cancer care. A few short decades ago, cancer treatment consisted mainly of three pillars: surgery, radiation and chemotherapy. Although each has earned its place as a valuable option, more precise alternatives have long been the oncologist’s dream.

Diamond honored with 2019 Stanley J. Korsmeyer Award (Links to an external site)

Mike Diamond Photo

Michael S. Diamond, MD, PhD, an infectious diseases specialist at Washington University School of Medicine in St. Louis, has been chosen as the recipient of the American Society for Clinical Investigation’s 2019 Stanley J. Korsmeyer Award. He is being honored for his contributions to understanding the molecular basis of disease caused by globally emerging RNA viruses such as the Zika, West Nile and chikungunya viruses.

Bonni, Diamond elected to National Academy of Medicine (Links to an external site)

Azad Bonni and Mike Diamond

Neuroscientist Azad Bonni, MD, PhD, and virologist and immunologist Michael S. Diamond, MD, PhD, both of Washington University School of Medicine in St. Louis, have been elected to the National Academy of Medicine, a part of the National Academy of Sciences. Membership in the organization is one of the highest honors in the fields of health and medicine in the United States.

Dunn awarded cancer fellowship (Links to an external site)

Gavin Dunn MD, PhD, a member of the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, focuses on glioblastoma, the most deadly form of brain cancer. He studies how the immune system recognizes brain cancer cells and how it can be harnessed to treat patients with glioblastoma.

$10 million gift creates Bursky Center for Human Immunology and Immunotherapy (Links to an external site)

CHiiPs Leaders at Work

Michael S. Diamond, MD, PhD, Robert D. Schreiber, PhD, and Wayne M. Yokoyama, MD, lead a team of investigators working to develop new immune-based therapies for cancer, infectious disease, autoimmunity and immunodeficiency in the newly named Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy at Washington University School of Medicine.

Washington University gets $10 million for immune system research (Links to an external site)

Bob Schreiber Photo

Andrew and Jane Bursky donated $10 million to Washington University for its research on using the immune system to fight diseases including cancer. The gift creates the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs and an endowed distinguished professorship for cancer immunologist Robert Schreiber, director of the center and an adviser to Vice President Joe Biden’s cancer moonshot project.